Premarket Mover: Aurinia Pharmaceuticals Inc (AUPH) Up 7.92%

Aurinia Pharmaceuticals Inc (AUPH) has risen Wednesday morning, with the stock rising 7.92% in pre-market trading to 8.86. AUPH's short-term technical score of 48 indicates that the stock has traded less bullishly over the last month than 52% of stocks on the market. In the Biotechnology industry, which ranks 109 out of 146 industries, Aurinia Pharmaceuticals Inc ranks higher than 55% of stocks. Aurinia Pharmaceuticals Inc has risen 81.24% over the past month, closing at $4.15 on December 28. During this period of time, the stock fell as low as $4.15 and as high as $9.55. AUPH has an average analyst recommendation of Strong Buy. The company has an average price target of $12.56.

AUPH has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on AUPH!

See Full AUPH Report

Aurinia Pharmaceuticals Inc has a Long-Term Technical rank of 34. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 66% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, AUPH ranks better than 126% of stocks.

Important Dates for Investors in AUPH:

-Aurinia Pharmaceuticals Inc is set to release earnings on 2/27/2023. Over the last 12 months, the company has reported EPS of $-0.83. -We do not have a set dividend date for Aurinia Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Aurinia Pharmaceuticals Inc (AUPH)